Update: Vaccine-preventable Infections and Immunization in Multiple Sclerosis
Practice Guideline, September 2019
Read Published ArticleSome evidence suggests that infections may trigger MS relapses, increase MS radiologic and immunologic activity, and accelerate disease progression. Select reports link immunizations to clinical exacerbations of MS. Thus, it is understandable that patients with MS may have concerns about receiving recommended immunizations. The purpose of the current update is to systematically evaluate and incorporate new evidence, vaccines, and disease-modifying therapies (DMTs).
Reaffirmed on October 22, 2022.
Endorsed by the Consortium of Multiple Sclerosis Centers and by the Multiple Sclerosis Association of America.
Clinician Tools and Materials
Full-length Version
Download a PDF of the full guideline product, including full details of the methodology and data analysis
Clinician Summary
Download a PDF summary of this guideline product
Clinical Algorithm
Access an interactive tool to assist with implementing the recommendations in this guideline product
Educational Materials
Other resources related to this guideline
Guideline Translations
Read guidelines in alternative languages
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.
Press Release
Download the AAN press release about this guideline product